Evidence map›Paper›PMID 34446740›Full record

ArticleScientific reports2021

Engineering and functional characterization of a proton-driven β-lactam antibiotic translocation module for bionanotechnological applications.

Mirko Stauffer, Zöhre Ucurum, Daniel Harder, Dimitrios Fotiadis

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Light Color-Controlled pH-Adjustment of Aqueous Solutions Using Engineered Proteoliposomes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mirko StaufferInstitute of Biochemistry and Molecular Medicine, University of Bern, 3012, Bern, Switzerland.
Zöhre UcurumInstitute of Biochemistry and Molecular Medicine, University of Bern, 3012, Bern, Switzerland.
Daniel HarderInstitute of Biochemistry and Molecular Medicine, University of Bern, 3012, Bern, Switzerland.
Dimitrios FotiadisInstitute of Biochemistry and Molecular Medicine, University of Bern, 3012, Bern, Switzerland. dimitrios.fotiadis@ibmm.unibe.ch.
University of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel approaches in synthetic biology focus on the bottom-up modular assembly of natural, modified natural or artificial components into molecular systems with functionalities not found in nature. A possible application for such techniques is the bioremediation of natural water sources contaminated with small organic molecules (e.g., drugs and pesticides). A simple molecular system to actively accumulate and degrade pollutants could be a bionanoreactor composed of a liposome or polymersome scaffold combined with energizing- (e.g., light-driven proton pump), transporting- (e.g., proton-driven transporter) and degrading modules (e.g., enzyme). This work focuses on the engineering of a transport module specific for β-lactam antibiotics. We previously solved the crystal structure of a bacterial peptide transporter, which allowed us to improve the affinity for certain β-lactam antibiotics using structure-based mutagenesis combined with a bacterial uptake assay. We were able to identify specific mutations, which enhanced the affinity of the transporter for antibiotics containing certain structural features. Screening of potential compounds allowed for the identification of a β-lactam antibiotic ligand with relatively high affinity. Transport of antibiotics was evaluated using a solid-supported membrane electrophysiology assay. In summary, we have engineered a proton-driven β-lactam antibiotic translocation module, contributing to the growing toolset for bionanotechnological applications.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamsBiological TransportBiotechnologyMembrane Transport ProteinsModels, MolecularMolecular StructureMutationNanotechnologyProtein BindingProtein DomainsProtein EngineeringProtonsYersinia enterocoliticaAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsMembrane Transport Proteinspeptide permeaseProtons

Identifiers

PMID34446740
PMCPMC8390754
OpenAlexW3194730144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.